Variability in response to anti-rheumatic drugs:
Gespeichert in:
Format: | Tagungsbericht Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Basel u.a.
Birkhäuser
1993
|
Schriftenreihe: | Agents and actions / Supplements
44 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literaturangaben |
Beschreibung: | 227 S. graph. Darst. |
ISBN: | 376432869X 081762869X |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV008188977 | ||
003 | DE-604 | ||
005 | 20010709 | ||
007 | t | ||
008 | 930823s1993 gw d||| |||| 00||| eng d | ||
020 | |a 376432869X |9 3-7643-2869-X | ||
020 | |a 081762869X |9 0-8176-2869-X | ||
035 | |a (OCoLC)28116347 | ||
035 | |a (DE-599)BVBBV008188977 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
044 | |a gw |c DE | ||
049 | |a DE-12 |a DE-355 |a DE-29 |a DE-188 | ||
050 | 0 | |a RM405 | |
082 | 0 | |a 615/.77 |2 20 | |
084 | |a XI 5100 |0 (DE-625)153011:12905 |2 rvk | ||
084 | |a XI 6805 |0 (DE-625)153023:12911 |2 rvk | ||
084 | |a MED 920f |2 stub | ||
084 | |a MED 556f |2 stub | ||
245 | 1 | 0 | |a Variability in response to anti-rheumatic drugs |c ed. by P. M. Brooks ... |
264 | 1 | |a Basel u.a. |b Birkhäuser |c 1993 | |
300 | |a 227 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Agents and actions / Supplements |v 44 | |
500 | |a Literaturangaben | ||
650 | 4 | |a Anti-inflammatoires non stéroïdiens | |
650 | 7 | |a Antireumatica |2 gtt | |
650 | 4 | |a Antirhumatismaux | |
650 | 4 | |a Anti-Inflammatory Agents |x pharmacokinetics | |
650 | 4 | |a Anti-Inflammatory Agents |x therapeutic use | |
650 | 4 | |a Antirheumatic agents | |
650 | 4 | |a Arthritis, Rheumatoid |x drug therapy | |
650 | 4 | |a Nonsteroidal anti-inflammatory agents | |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Wirkung |0 (DE-588)4190021-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Antirheumatikum |0 (DE-588)4002332-1 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1992 |z Singapur |2 gnd-content | |
689 | 0 | 0 | |a Antirheumatikum |0 (DE-588)4002332-1 |D s |
689 | 0 | 1 | |a Wirkung |0 (DE-588)4190021-2 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Antirheumatikum |0 (DE-588)4002332-1 |D s |
689 | 1 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Brooks, Peter M. |e Sonstige |4 oth | |
711 | 2 | |a CPT |n 5 |d 1992 |c Yokohama |j Sonstige |0 (DE-588)2130140-2 |4 oth | |
810 | 2 | |a Supplements |t Agents and actions |v 44 |w (DE-604)BV001899350 |9 44 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005405029&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-005405029 |
Datensatz im Suchindex
_version_ | 1804122575258779648 |
---|---|
adam_text | Q P F ) R ^ VARIABILITY IN RESPONSE TO ANTI-RHEUMATIC DRUGS EDITED BY
P.M. BROOKS R.O. DAY G.G. GRAHAM K.M. WILLIAMS BIRKHAUSER VERLAG BASEL
BOSTON * BERLIN CONTENTS PREFACE IX NON-STEROIDAL ANTI-INFLAMMATORY
DRUGS R.O. DAY VARIABILITY IN RESPONSE TO N S A I D S : W H A T
PROGRESS? .... P. SEIDEMAN PARACETAMOL IN RHEUMATOID ARTHRITIS
STEREOCHEMICAL CONTRIBUTIONS TO VARIABILITY IN RESPONSE TO NSAIDS K.M.
WILLIAMS CHIRAL NSAIDS: SO WHAT? 15 S. MENZEL-SOGLOWEK, G. GEISSLINGER
AND K. BRUNE METABOLIC CHIRAL INVERSION OF 2-ARYLPROPIONATES IN
DIFFERENT TUMOR CELL LINES 23 G. GEISSLINGER, S. MENZEL-SOGLOWEK AND K.
BRUNE (R)-FLURBIPROFEN: ISOMERIC BALLAST OR ACTIVE ENTITY OF THE RACEMIC
COMPOUND 31 FURTHER FACTORS LEADING TO VARIABILITY IN RESPONSE TO NSAIDS
K.D. RAINSFORD MECHANISMS OF NSAIDS ON JOINT DESTRUCTION IN
OSTEOARTHRITIS 39 P. NETTER, B. BANNWARTH, F. LAPICQUEL, F.
DEMOTES-MAINARD, T. SCHCEVERBEKE AND P. GILLET PHARMACOKINETICS AND
PHARMACODYNAMICS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN SYNOVIAL
FLUID 45 K. BRUNE, B. NUERNBERG AND H. T. SCHNEIDER BILIARY ELIMINATION
OF ASPIRIN AFTER ORAL AND INTRAVENOUS ADMINISTRATION IN PATIENTS ... 51
K.D. RAINSFORD MECHANISMS OF GASTROINTESTIAL DAMAGE BY NSAIDS 59 TRIALS
AND TRIAL DESIGN T. PINCUS AND L. F. CALLAHAN VARIABILITY IN INDIVIDUAL
RESPONSES OF 532 PATIENTS WITH RHEUMATOID ARTHRITIS TO FIRST- LINE AND
SECOND-LINE DRUGS 67 M.HYLIANG AND R.B. BRIGHAM TOWARDS MORE INFORMATIVE
PILOT STUDIES WITH NEW ANTI-RHEUMATIC DRUGS 77 T. PINCUS LIMITATIONS TO
STANDARD RANDOMIZED CONTROLLED CLINICAL TRIALS TO EVALUATE COMBINATION
THERAPIES IN RHEUMATIC DISEASES 83 COMBINATION THERAPY P.M. BROOKS
COMBINATION THERAPY IN RHEUMATOID ARTHRITIS 95 M. NOBUNAGA AND M. YASUDA
COMPARISON OF CLINICAL EFFECTS OF BUCILLAMINE BETWEEN ADDITIVE
COMBINATION AND SINGLE ADMINISTRATION STUDY IN RHEUMATOID ARTHRITIS 105
DISEASE MODIFYING ANTI-RHEUMATIC DRUGS MODE OF ACTION OF DMARDS A. C.
ALLISON AND R. V. WATERS LONG-ACTING ANTI-RHEUMATIC DRUGS INDUCE
DIFFERENTIATION OF CELLS OF THE MONOCYTE- MACROPHAGE LINEAGE AND ALTER
THE EXPRESSION OF CYTOKINES AND IL-1 RECEPTOR ANTAGONIST . 113
METHOTREXATE AND ANTIMALARIALS D.E. FURST METHOTREXATE: NEW MECHANISMS
AND OLD TOXICITIES 131 D.J. CUTLER POSSIBLE MECHANISMS OF ACTION OF
ANTIMALARIALS IN RHEUMATIC DISEASE 139 S. TETT, A. MCLACHLAN, R. O. DAY
AND D.J. CUTLER INSIGHTS FROM PHARMACOKINETIC AND PHARMACODYNAMIC
STUDIES OF HYDROXYCHLOROQUINE . 145 R.I. RYNES TOXICITY OF ANTIMALARIAL
DRUGS IN RHEUMATOID ARTHRITIS 151 DMARDS: NEW AND OLD P.M. BROOKS
TENIDAP: ANEW ANTIARTHRITIC AGENT 161 A.C. ALLISON AND E.M. EUGUI
IMMUNOSUPPRESSIVE AND OTHER ANTI-RHEUMATIC ACTIVITIES OF MYCOPHENOLATE
MOFETIL . . . 165 MJ. PAMHAMANDD.R. BLAKE ANTIOXIDANTS AS
ANTI-RHEUMATICS 189 M. DOUGADOS SULPHASALAZINE IN RHEUMATIC DISEASES 197
D.A. JOYCE VARIABILITY IN RESPONSE TO D-PENICILLAMINE: PHARMACOKINETIC
INSIGHTS 203 G.G. GRAHAM, J.B. ZIEGLER AND G.D. CHAMPION MEDICINAL
CHEMISTRY OF GOLD 209 M.L. HANDEL, S. SIVERTSEN, C.K.W. WATTS, R.O.
DAYANDR.L. SUTHERLAND COMPARATIVE EFFECTS OF GOLD ON THE INTERACTIONS OF
TRANSCRIPTION FACTORS WITH DNA . . . 219 SUBJECT INDEX 225
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV008188977 |
callnumber-first | R - Medicine |
callnumber-label | RM405 |
callnumber-raw | RM405 |
callnumber-search | RM405 |
callnumber-sort | RM 3405 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | XI 5100 XI 6805 |
classification_tum | MED 920f MED 556f |
ctrlnum | (OCoLC)28116347 (DE-599)BVBBV008188977 |
dewey-full | 615/.77 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.77 |
dewey-search | 615/.77 |
dewey-sort | 3615 277 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Conference Proceeding Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02407nam a2200625 cb4500</leader><controlfield tag="001">BV008188977</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20010709 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930823s1993 gw d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">376432869X</subfield><subfield code="9">3-7643-2869-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">081762869X</subfield><subfield code="9">0-8176-2869-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28116347</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008188977</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM405</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.77</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5100</subfield><subfield code="0">(DE-625)153011:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 6805</subfield><subfield code="0">(DE-625)153023:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 920f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 556f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Variability in response to anti-rheumatic drugs</subfield><subfield code="c">ed. by P. M. Brooks ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel u.a.</subfield><subfield code="b">Birkhäuser</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">227 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Agents and actions / Supplements</subfield><subfield code="v">44</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-inflammatoires non stéroïdiens</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antireumatica</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antirhumatismaux</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Inflammatory Agents</subfield><subfield code="x">pharmacokinetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Inflammatory Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antirheumatic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arthritis, Rheumatoid</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nonsteroidal anti-inflammatory agents</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkung</subfield><subfield code="0">(DE-588)4190021-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antirheumatikum</subfield><subfield code="0">(DE-588)4002332-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1992</subfield><subfield code="z">Singapur</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antirheumatikum</subfield><subfield code="0">(DE-588)4002332-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wirkung</subfield><subfield code="0">(DE-588)4190021-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Antirheumatikum</subfield><subfield code="0">(DE-588)4002332-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brooks, Peter M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">CPT</subfield><subfield code="n">5</subfield><subfield code="d">1992</subfield><subfield code="c">Yokohama</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)2130140-2</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplements</subfield><subfield code="t">Agents and actions</subfield><subfield code="v">44</subfield><subfield code="w">(DE-604)BV001899350</subfield><subfield code="9">44</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005405029&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005405029</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1992 Singapur gnd-content |
genre_facet | Konferenzschrift 1992 Singapur |
id | DE-604.BV008188977 |
illustrated | Illustrated |
indexdate | 2024-07-09T17:16:03Z |
institution | BVB |
institution_GND | (DE-588)2130140-2 |
isbn | 376432869X 081762869X |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005405029 |
oclc_num | 28116347 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-29 DE-188 |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-29 DE-188 |
physical | 227 S. graph. Darst. |
publishDate | 1993 |
publishDateSearch | 1993 |
publishDateSort | 1993 |
publisher | Birkhäuser |
record_format | marc |
series2 | Agents and actions / Supplements |
spelling | Variability in response to anti-rheumatic drugs ed. by P. M. Brooks ... Basel u.a. Birkhäuser 1993 227 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Agents and actions / Supplements 44 Literaturangaben Anti-inflammatoires non stéroïdiens Antireumatica gtt Antirhumatismaux Anti-Inflammatory Agents pharmacokinetics Anti-Inflammatory Agents therapeutic use Antirheumatic agents Arthritis, Rheumatoid drug therapy Nonsteroidal anti-inflammatory agents Pharmakologie (DE-588)4045687-0 gnd rswk-swf Wirkung (DE-588)4190021-2 gnd rswk-swf Antirheumatikum (DE-588)4002332-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1992 Singapur gnd-content Antirheumatikum (DE-588)4002332-1 s Wirkung (DE-588)4190021-2 s DE-604 Pharmakologie (DE-588)4045687-0 s Brooks, Peter M. Sonstige oth CPT 5 1992 Yokohama Sonstige (DE-588)2130140-2 oth Supplements Agents and actions 44 (DE-604)BV001899350 44 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005405029&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Variability in response to anti-rheumatic drugs Anti-inflammatoires non stéroïdiens Antireumatica gtt Antirhumatismaux Anti-Inflammatory Agents pharmacokinetics Anti-Inflammatory Agents therapeutic use Antirheumatic agents Arthritis, Rheumatoid drug therapy Nonsteroidal anti-inflammatory agents Pharmakologie (DE-588)4045687-0 gnd Wirkung (DE-588)4190021-2 gnd Antirheumatikum (DE-588)4002332-1 gnd |
subject_GND | (DE-588)4045687-0 (DE-588)4190021-2 (DE-588)4002332-1 (DE-588)1071861417 |
title | Variability in response to anti-rheumatic drugs |
title_auth | Variability in response to anti-rheumatic drugs |
title_exact_search | Variability in response to anti-rheumatic drugs |
title_full | Variability in response to anti-rheumatic drugs ed. by P. M. Brooks ... |
title_fullStr | Variability in response to anti-rheumatic drugs ed. by P. M. Brooks ... |
title_full_unstemmed | Variability in response to anti-rheumatic drugs ed. by P. M. Brooks ... |
title_short | Variability in response to anti-rheumatic drugs |
title_sort | variability in response to anti rheumatic drugs |
topic | Anti-inflammatoires non stéroïdiens Antireumatica gtt Antirhumatismaux Anti-Inflammatory Agents pharmacokinetics Anti-Inflammatory Agents therapeutic use Antirheumatic agents Arthritis, Rheumatoid drug therapy Nonsteroidal anti-inflammatory agents Pharmakologie (DE-588)4045687-0 gnd Wirkung (DE-588)4190021-2 gnd Antirheumatikum (DE-588)4002332-1 gnd |
topic_facet | Anti-inflammatoires non stéroïdiens Antireumatica Antirhumatismaux Anti-Inflammatory Agents pharmacokinetics Anti-Inflammatory Agents therapeutic use Antirheumatic agents Arthritis, Rheumatoid drug therapy Nonsteroidal anti-inflammatory agents Pharmakologie Wirkung Antirheumatikum Konferenzschrift 1992 Singapur |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005405029&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV001899350 |
work_keys_str_mv | AT brookspeterm variabilityinresponsetoantirheumaticdrugs AT cptyokohama variabilityinresponsetoantirheumaticdrugs |